Trials / Recruiting
RecruitingNCT03302195
Optimal Cardiopulmonary Bypass and Anticoagulation Management Strategies in Obese Patients Undergoing Cardiac Surgery
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 410 (estimated)
- Sponsor
- Laval University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Standard Heparin management, based on total body weight, is not well established for obese patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). The purpose of this study is to assess the safety and efficacy of using lean body mass (LBM) to determine pump flow rate and/or Heparin dosage in obese patients undergoing CPB.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Heparin | Based on patient body weight (UI/kg) |
| PROCEDURE | cardiopulmonary bypass pump flow rate | Based on patient body weight (L/min/m2) |
Timeline
- Start date
- 2015-08-21
- Primary completion
- 2024-12-31
- Completion
- 2027-12-31
- First posted
- 2017-10-05
- Last updated
- 2023-03-10
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03302195. Inclusion in this directory is not an endorsement.